Pacific Biosciences of California, Inc. (PACB)
NMS – Real Time Price. Currency in USD
1.10
-0.04 (-3.51%)
Market open: Aug 12, 2026, 1:31 PM EDT
1.16
+0.02 (1.71%)
Previous after-hours: Aug 11, 2026, 7:52 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
1.10
-0.04 (-3.51%)
Market open: Aug 12, 2026, 1:31 PM EDT
1.16
+0.02 (1.71%)
Previous after-hours: Aug 11, 2026, 7:52 PM EDT
No Data
There are no news for this stock.
Total debt $706.1M significantly exceeds cash reserves ($61.0M), raising financial stability concerns
Total current assets $338.6M exceed Total current liabilities $68.8M, highlighting excellent liquidity
Debt-to-equity ratio (-21.3) is well below the industry average (1.1), showcasing prudent financial management
Interest coverage ratio (-21.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$37.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.92 | 3.40 | 10 | |
| Quick ratio | 4.03 | 2.52 | 10 | |
| Debt to Equity | N/A | 1.11 | 1.0 | |
| Debt to Assets | 0.94 | 1.58 | 2.0 | |
| Interest coverage | -21.14 | 4.33 | 1.0 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 128M | 201M | 154M | 160M | 159M |
| Gross Profit | 49M | 40M | 24M | -319M | 55M |
| Operating Income | -305M | -310M | -265M | -552M | -162M |
| Net Income | -314M | -307M | -310M | -546M | -131M |
| EBITDA | -288M | -278M | -212M | -165M | -145M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 2.76 | 0 | 2.5 |
| Next quarter | -2.65 | -1.28 | 1.0 |
| Current year | -0.44 | 75.46 | 5.5 |
| Next year | 16.75 | -2.98 | 5.0 |
| Weighted average score | 3.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 4.92 | -440.67 | -366.66 | 22.2 | 4.0 |
| Y/Y | -1.9 | -6.69 | 0 | -24.09 | 1.0 |
| 3y average | 12.33 | -24.97 | -13.82 | 23.63 | 4.8 |
| 5y average | 20.15 | -172.92 | -144.45 | -160.47 | 3.3 |
| Weighted average score | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |